Skip to main content

AMPAR2 Encephalopathy: A Recently Described Reversible Cause of Cognitive Impairment

AMLI 2021: 34th Annual Scientific Meeting (The Association of medical Laboratory Immunologists)
Austin, TX, August 13-16, 2021

AMPAR2 Encephalopathy: A Recently Described Reversible Cause of Cognitive Impairment

Authors: Luo A, Saadatpour L, Tanwir A, Naides SJ, Parker AS

Specialties: Neurology, Immunology